PRGF Effectiveness for Myofascial Pain Treatment in Masticatory Muscles

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

August 20, 2019

Study Completion Date

August 25, 2019

Conditions
Myofascial Pain
Interventions
BIOLOGICAL

PRGF injection

Plasma rich in growth factors will be prepared following the protocol described by E. Anitua. 9 ml of patients venous blood will be taken into one tube with 3,8% sodium citrate used as an anticoagulant. The blood then will be centrifuged (PRGF Centrifuge System, Biotechnology Institute, Vitoria, Spain) at room temperature for 8 min at 1800 rpm. After centrifugation 1 ml of 2nd plasma fraction will be collected by using a pipet. To activate plasma 10% calcium chloride will be used immediately before injecting plasma into the trigger point in the masseter muscle.

DRUG

Lidocaine injection

1 ml 2 % Lidocaine will be injected into the trigger point in the patient's masseter muscle.

Trial Locations (1)

LT-50161

LUHS Kaunas clinics Department of Maxillofacial surgery, Kaunas

All Listed Sponsors
lead

Lithuanian University of Health Sciences

OTHER

NCT04040309 - PRGF Effectiveness for Myofascial Pain Treatment in Masticatory Muscles | Biotech Hunter | Biotech Hunter